Weekly Peel Pads
A weekly exfoliating pad that offers a high-potency combination of alpha (glycolic, lactic) and beta (salicylic) hydroxyacids. Gently removes and decongests dead skin cells that can diminish a healthy-looking appearance. Weekly use will leave your complexion feeling velvety soft and radiant.
- 10% Glycolic, 10% Lactic Acid & 5% Salicylic Acid act to inhibit pigment formation.
- Gently exfoliates removing dead skin cells that can clog pores.
- Helps to fade discoloration of the skin.
- Diminishes the look of lines and wrinkles.
- Salicylic Acid boosts penetration.
- Reveals fresh, healthy looking skin.
INSTRUCTIONS FOR USE: Use once or twice weekly. Smooth pad over areas to be treated. On first use, rinse off after approximately 15 minutes. If tolerated, contact time may be increased to overnight.
CAUTION: For external use only. Use only as directed. Discontinue use if irritation occurs. Avoid direct contact with eyes. Keep out of reach of children.
SKIN TYPES: Mature | oily | acne prone | photo-aged
- Reviews (0)
10% Glycolic Acid: An alpha hydroxy acid (AHA) that removes the outer layer of dead skin cells on your skin, bringing fresh, new skin to the surface. Often used to help fade discoloration of the skin, such as sun spots or age spots and used by those with acne-prone and blackhead-prone skin.
10% Lactic Acid: This alpha hydroxy acid (AHA) penetrates the oil glands, removing built up dirt and debris from deep within the pores so that skin is left looking smoother and more even.
5% Salicylic acid: A Beta-Hydroxy Acid that causes skin cells to shed more readily, opening clogged pores and neutralizing bacteria; can also constrict pore diameter; provides a hostile environment for bacteria growth. It is also beneficial for minor lightening of discoloration or hyperpigmentation that result from the acne.
Green Tea extract: Provides anti-oxidant protection and helps reduce the signs of aging and sun damage.
Only logged in customers who have purchased this product may leave a review.
There are no reviews yet.